Showing results (211-220 of 264) with videos related to
Sort By:
Pageof 27
Cancer Immunology Research|March 19, 2020
A PSMA-Targeting CD3 Bispecific Antibody Induces Antitumor Responses that Are Enhanced by 4-1BB CostimulationDanica Chiu, Richard Tavaré, Lauric Haber, et al.Journal of Occupational and Environmental Medicine|March 4, 2022
Occupational and Environmental Hazards of Correctional Settings: A Scoping Literature Review From ACOEM's Presidential Task Force on Correctional InstitutionsAndre Montoya-Barthelemy, Brent R Gibson, Charles D Lee, et al.Blood Advances|March 2, 2021
A BCMAxCD3 bispecific T cell-engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cellsDavid J DiLillo, Kara Olson, Katja Mohrs, et al.Frontiers in Immunology|March 30, 2023
Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiationBimala Dhakal, Celine Man Ying Li, Mahnaz Ramezanpour, et al.Research Square|September 5, 2025
Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistanceAllie Grossmann, Junhua Wang, Yinshen Wee, et al.Molecular Cancer|October 4, 2008
Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinomaEric Smith, Neville J De Young, Sandra J Pavey, et al.Applied Neuropsychology. Child|March 7, 2020
Psychometric properties of the standardized assessment of concussion in youth football: Validity, reliability, and demographic factorsArthur Maerlender, Eric Smith, P Gunnar Brolinson, et al.Science Advances|January 21, 2026
Optimally engineered HLA/peptide-specific CAR-T cells outperform TCR-T cells to eradicate solid tumorsCorinne E Decker, Jacqueline Idun, Katja Mohrs, et al.JID Innovations : Skin Science From Molecules to Population Health|May 25, 2026
CIT tumor lines: A series of immunogenic murine cutaneous squamous cell carcinoma cell lines derived from chemical carcinogenesisRobert Letchworth, Miho Tanaka, Alina A Barnes, et al.Nature Communications|July 18, 2023
Mislocalization of pathogenic RBM20 variants in dilated cardiomyopathy is caused by loss-of-interaction with Transportin-3Julia Kornienko, Marta Rodríguez-Martínez, Kai Fenzl, et al.Pageof 27